Organization Profile

You just read:

Soliris® (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (aHUS)

News provided by

Alexion Pharmaceuticals, Inc.

Nov 09, 2013, 21:23 ET